Presenting Author: Sharat Singh, PhD, Head of Research, Biora Therapeutics, Inc. About the BioJet™ Systemic Oral Delivery PlatformBiora's BioJet systemic oral therapeutics platform uses an ingestible ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced the publication of new data in the journal Molecular Therapy by ...
Study published in Molecular Therapy found factors affecting pharmacodynamics and described stability. Alnylam Pharmaceuticals and researchers from the Massachusetts Institute of Technology (MIT) ...
Dr. Singh will also participate in a panel discussion on June 19 at 8:45 AM titled “Uncovering Innovations in Peptide Drug Delivery & Formulation for Improved Bioavailability,” alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback